{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T18:25:48Z","timestamp":1787509548516,"version":"build-2736575974"},"reference-count":109,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T00:00:00Z","timestamp":1694390400000},"content-version":"vor","delay-in-days":163,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.canlet.2023.216125","type":"journal-article","created":{"date-parts":[[2023,3,11]],"date-time":"2023-03-11T19:33:54Z","timestamp":1678563234000},"page":"216125","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Valproate and lithium: Old drugs for new pharmacological approaches in brain tumors?"],"prefix":"10.1016","volume":"560","author":[{"given":"Gianfranco","family":"Natale","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Fini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasquale Fabio","family":"Calabr\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Carli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Scarselli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7120-9141","authenticated-orcid":false,"given":"Guido","family":"Bocci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2023.216125_bib1","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrd1468","article-title":"Drug repositioning: identifying and developing new uses for existing drugs","volume":"3","author":"Ashburn","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.canlet.2023.216125_bib2","first-page":"651","article-title":"New drugs are not enough-drug repositioning in oncology: an update","volume":"56","author":"Armando","year":"2020","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.canlet.2023.216125_bib3","doi-asserted-by":"crossref","first-page":"4093","DOI":"10.2174\/09298673113209990193","article-title":"Discovering new anticancer activities from old drugs","volume":"20","author":"Wu","year":"2013","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.canlet.2023.216125_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.ypmed.2022.107169","article-title":"The efficacy of chemopreventive agents on the incidence of colorectal adenomas: a systematic review and network meta-analysis","volume":"162","author":"Heer","year":"2022","journal-title":"Prev. Med."},{"key":"10.1016\/j.canlet.2023.216125_bib5","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s11523-022-00897-8","article-title":"What\u2019s old is new: the past, present and future role of thalidomide in the modern-day management of multiple myeloma","volume":"17","author":"Costa","year":"2022","journal-title":"Target. Oncol."},{"key":"10.1016\/j.canlet.2023.216125_bib6","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1038\/s41416-022-01882-8","article-title":"Non-aspirin non-steroidal anti-inflammatory drugs in colorectal cancer: a review of clinical studies","volume":"127","author":"Zaman","year":"2022","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.canlet.2023.216125_bib7","doi-asserted-by":"crossref","first-page":"7222","DOI":"10.2174\/0929867327666200713190520","article-title":"Drugs repurposing in high-grade serous ovarian cancer","volume":"27","author":"Torralba","year":"2020","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.canlet.2023.216125_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232314957","article-title":"Evidence for multilevel chemopreventive activities of natural phenols from functional genomic studies of curcumin, resveratrol, genistein, quercetin, and luteolin","volume":"23","author":"Huminiecki","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.canlet.2023.216125_bib9","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.canlet.2021.12.014","article-title":"Drug repositioning: using psychotropic drugs for the treatment of glioma","volume":"527","author":"You","year":"2022","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2023.216125_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104786","article-title":"Epileptogenesis and oncogenesis: an antineoplastic role for antiepileptic drugs in brain tumours?","volume":"156","author":"Cucchiara","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.canlet.2023.216125_bib11","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/med.10017","article-title":"Anti-tumor mechanisms of valproate: a novel role for an old drug","volume":"22","author":"Blaheta","year":"2002","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.canlet.2023.216125_bib12","first-page":"132","article-title":"Induction of neutrophilic differentiation of human promyelocytic leukemic cells by branched-chain carboxylic acid anticonvulsant drugs","volume":"3","author":"Fischkoff","year":"1984","journal-title":"J. Biol. Response Modif."},{"key":"10.1016\/j.canlet.2023.216125_bib13","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/0006-8993(85)90207-0","article-title":"Therapeutic levels of sodium valproate inhibit mitotic indices in cells of neural origin","volume":"347","author":"Regan","year":"1985","journal-title":"Brain Res."},{"key":"10.1016\/j.canlet.2023.216125_bib14","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1528-1157.1987.tb04210.x","article-title":"Effects of anticonvulsants on cell growth and enzymatic and receptor binding activity in a neuroblastoma x glioma hybrid cell culture","volume":"28","author":"Slesinger","year":"1987","journal-title":"Epilepsia"},{"key":"10.1016\/j.canlet.2023.216125_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112021","article-title":"Hidden pharmacological activities of valproic acid: a new insight","volume":"142","author":"Singh","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.canlet.2023.216125_bib16","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0006-8993(91)90193-Y","article-title":"The anticonvulsant valproate teratogen restricts the glial cell cycle at a defined point in the mid-G1 phase","volume":"554","author":"Martin","year":"1991","journal-title":"Brain Res."},{"key":"10.1016\/j.canlet.2023.216125_bib17","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1046\/j.1471-4159.2002.01081.x","article-title":"Antiproliferative action of valproate is associated with aberrant expression and nuclear translocation of cyclin D3 during the C6 glioma G1 phase","volume":"83","author":"Bacon","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.canlet.2023.216125_bib18","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0736-5748(97)00019-1","article-title":"Valproic acid suppresses G1 phase-dependent sialylation of a 65kDa glycoprotein in the C6 glioma cell cycle","volume":"15","author":"Bacon","year":"1997","journal-title":"Int. J. Dev. Neurosci."},{"key":"10.1016\/j.canlet.2023.216125_bib19","doi-asserted-by":"crossref","first-page":"6085","DOI":"10.1007\/s11033-021-06616-2","article-title":"Effect of valproic acid on miRNAs affecting histone deacetylase in a model of anaplastic thyroid cancer","volume":"48","author":"Gunel","year":"2021","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.canlet.2023.216125_bib20","doi-asserted-by":"crossref","first-page":"6969","DOI":"10.1093\/emboj\/20.24.6969","article-title":"Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells","volume":"20","author":"G\u00f6ttlicher","year":"2001","journal-title":"EMBO J."},{"key":"10.1016\/j.canlet.2023.216125_bib21","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/cncr.22891","article-title":"Valproic acid for the treatment of myeloid malignancies","volume":"110","author":"Kuendgen","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.canlet.2023.216125_bib22","doi-asserted-by":"crossref","first-page":"L79","DOI":"10.1016\/0024-3205(92)90104-W","article-title":"Segregation of the growth slowing effects of valproic acid from phenytoin and carbamazepine on lymphoid tumor cells","volume":"50","author":"Tittle","year":"1992","journal-title":"Life Sci."},{"key":"10.1016\/j.canlet.2023.216125_bib23","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/j.1528-1157.1992.tb02354.x","article-title":"Effect of antiepileptic drugs on growth of murine lymphoid tumor cells in single-cell culture","volume":"33","author":"Tittle","year":"1992","journal-title":"Epilepsia"},{"key":"10.1016\/j.canlet.2023.216125_bib24","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.canlet.2011.12.041","article-title":"Valproic acid triggers differentiation and apoptosis in AML1\/ETO-positive leukemic cells specifically","volume":"319","author":"Zapotocky","year":"2012","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2023.216125_bib25","first-page":"573","article-title":"Valproic acid induces non-apoptotic cell death mechanisms in multiple myeloma cell lines","volume":"30","author":"Schwartz","year":"2007","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.canlet.2023.216125_bib26","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0300-483X(03)00331-7","article-title":"Sodium valproate induces apoptosis in the rat hepatoma cell line, FaO","volume":"192","author":"Phillips","year":"2003","journal-title":"Toxicology"},{"key":"10.1016\/j.canlet.2023.216125_bib27","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/s12029-020-00370-7","article-title":"Sodium valproate, a histone deacetylase inhibitor, provokes reactive oxygen species-mediated cytotoxicity in human hepatocellular carcinoma cells","volume":"52","author":"Rithanya","year":"2021","journal-title":"J. Gastrointest. Cancer"},{"key":"10.1016\/j.canlet.2023.216125_bib28","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1093\/abbs\/gmab002","article-title":"Inhibition of lipogenesis and induction of apoptosis by valproic acid in prostate cancer cells via the C\/EBP\u03b1\/SREBP-1 pathway","volume":"53","author":"Pang","year":"2021","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"10.1016\/j.canlet.2023.216125_bib29","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3390\/cells7090129","article-title":"HDAC inhibition counteracts metastatic Re-activation of prostate cancer cells induced by chronic mTOR suppression","volume":"7","author":"Makarevi\u0107","year":"2018","journal-title":"Cells"},{"key":"10.1016\/j.canlet.2023.216125_bib30","doi-asserted-by":"crossref","first-page":"3409","DOI":"10.3390\/cancers13143409","article-title":"Valproic acid and breast cancer: state of the art in 2021","volume":"13","author":"Wawruszak","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.canlet.2023.216125_bib31","doi-asserted-by":"crossref","DOI":"10.1177\/09636897211027524","article-title":"Valproic acid suppresses breast cancer cell growth through triggering pyruvate kinase M2 isoform mediated Warburg effect","volume":"30","author":"Li","year":"2021","journal-title":"Cell Transplant."},{"key":"10.1016\/j.canlet.2023.216125_bib32","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1007\/s12029-019-00332-8","article-title":"Evaluation of the effects of valproic acid treatment on cell survival and epithelial-mesenchymal transition-related features of human gastric cancer cells","volume":"52","author":"Jahani","year":"2021","journal-title":"J. Gastrointest. Cancer"},{"key":"10.1016\/j.canlet.2023.216125_bib33","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1097\/SLA.0b013e3181758d0e","article-title":"Valproic acid activates Notch1 signaling and induces apoptosis in medullary thyroid cancer cells","volume":"247","author":"Greenblatt","year":"2008","journal-title":"Ann. Surg."},{"key":"10.1016\/j.canlet.2023.216125_bib34","article-title":"Combination of arsenic trioxide and valproic acid efficiently inhibits growth of lung cancer cells via G2\/M-phase arrest and apoptotic cell death","volume":"21","author":"Park","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.canlet.2023.216125_bib35","doi-asserted-by":"crossref","DOI":"10.1186\/s13578-019-0312-0","article-title":"Combination chemotherapy of valproic acid (VPA) and gemcitabine regulates STAT3\/Bmi1 pathway to differentially potentiate the motility of pancreatic cancer cells","volume":"9","author":"Li","year":"2019","journal-title":"Cell Biosci."},{"key":"10.1016\/j.canlet.2023.216125_bib36","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1007\/s12094-016-1494-0","article-title":"Valproic acid inhibits the angiogenic potential of cervical cancer cells via HIF-1\u03b1\/VEGF signals","volume":"18","author":"Zhao","year":"2016","journal-title":"Clin. Transl. Oncol."},{"key":"10.1016\/j.canlet.2023.216125_bib37","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.3892\/or.2015.4145","article-title":"Valproic acid suppresses the self-renewal and proliferation of head and neck cancer stem cells","volume":"34","author":"Lee","year":"2015","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.canlet.2023.216125_bib38","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1177\/1073858421992316","article-title":"Historical overview of the \u201cfiring\u201d liaison between brain tumors and epilepsy","volume":"28","author":"Natale","year":"2022","journal-title":"Neuroscientist"},{"key":"10.1016\/j.canlet.2023.216125_bib39","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.semradonc.2015.02.009","article-title":"Clinical management of seizures in patients with low-grade glioma","volume":"25","author":"Piotrowski","year":"2015","journal-title":"Semin. Radiat. Oncol."},{"key":"10.1016\/j.canlet.2023.216125_bib40","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/med.10017","article-title":"Anti-tumor mechanisms of valproate: a novel role for an old drug","volume":"22","author":"Blaheta","year":"2002","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.canlet.2023.216125_bib41","doi-asserted-by":"crossref","DOI":"10.1093\/noajnl\/vdz025","article-title":"Effects of valproic acid on histone deacetylase inhibition in vitro and in glioblastoma patient samples","volume":"1","author":"Berendsen","year":"2019","journal-title":"Neuro-Oncology Adv."},{"key":"10.1016\/j.canlet.2023.216125_bib42","doi-asserted-by":"crossref","first-page":"463","DOI":"10.7314\/APJCP.2016.17.2.463","article-title":"Roles of valproic acid in improving radiation therapy for glioblastoma: a review of literature focusing on clinical evidence","volume":"17","author":"Ochiai","year":"2016","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/j.canlet.2023.216125_bib43","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1093\/nop\/npab030","article-title":"Efficacy of antiepileptic drugs in glioma patients with epilepsy: a systematic review","volume":"8","author":"De Bruin","year":"2021","journal-title":"Neuro-Oncology Pract."},{"key":"10.1016\/j.canlet.2023.216125_bib44","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1007\/s10571-020-00930-2","article-title":"Valproic acid sensitizes glioma cells to luteolin through induction of apoptosis and autophagy via Akt signaling","volume":"41","author":"Han","year":"2021","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.canlet.2023.216125_bib45","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/s002130100871","article-title":"Chronic lithium treatment increases the expression of brain-derived neurotrophic factor in the rat brain","volume":"158","author":"Fukumoto","year":"2001","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.canlet.2023.216125_bib46","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1111\/j.1471-4159.2005.03457.x","article-title":"Novel targets for valproic acid: up-regulation of melatonin receptors and neurotrophic factors in C6 glioma cells","volume":"95","author":"Castro","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.canlet.2023.216125_bib47","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1517\/13543784.2012.694425","article-title":"Valproic acid for the treatment of malignant gliomas: review of the preclinical rationale and published clinical results","volume":"21","author":"Berendsen","year":"2012","journal-title":"Expet Opin. Invest. Drugs"},{"key":"10.1016\/j.canlet.2023.216125_bib48","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.687362","article-title":"Valproic acid: a promising therapeutic agent in glioma treatment","volume":"11","author":"Han","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.canlet.2023.216125_bib49","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1159\/000447912","article-title":"Valproic acid promotes human glioma U87 cells apoptosis and inhibits glycogen synthase kinase-3\u03b2 through ERK\/Akt signaling","volume":"39","author":"Zhang","year":"2016","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.canlet.2023.216125_bib50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/0963689720981878","article-title":"Valproic acid enhanced apoptosis by promoting autophagy via akt\/mTOR signaling in glioma","volume":"29","author":"Han","year":"2020","journal-title":"Cell Transplant."},{"key":"10.1016\/j.canlet.2023.216125_bib51","doi-asserted-by":"crossref","first-page":"186","DOI":"10.2176\/nmc.52.186","article-title":"Valproic acid inhibits angiogenesis in vitro and glioma angiogenesis in vivo in the brain","volume":"52","author":"Osuka","year":"2012","journal-title":"Neurol. Med.-Chir."},{"key":"10.1016\/j.canlet.2023.216125_bib52","first-page":"1","article-title":"Valproic acid inhibits glioma and its mechanisms","volume":"2022","author":"Yang","year":"2022","journal-title":"J. Healthc. Eng."},{"key":"10.1016\/j.canlet.2023.216125_bib53","doi-asserted-by":"crossref","first-page":"iii1","DOI":"10.1093\/neuonc\/noac161","article-title":"CBTRUS statistical report: pediatric brain tumor foundation childhood and adolescent primary brain and other central nervous system tumors diagnosed in the United States in 2014-2018","volume":"24","author":"Ostrom","year":"2022","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.canlet.2023.216125_bib54","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/s41571-022-00643-z","article-title":"Advancing therapy for neuroblastoma","volume":"19","author":"Qiu","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.canlet.2023.216125_bib55","first-page":"1795","article-title":"Valproic acid and interferon-alpha synergistically inhibit neuroblastoma cell growth in vitro and in vivo","volume":"25","author":"Michaelis","year":"2004","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.canlet.2023.216125_bib56","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.bbrc.2018.11.103","article-title":"Valproic acid suppresses Warburg effect and tumor progression in neuroblastoma","volume":"508","author":"Fang","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.canlet.2023.216125_bib57","doi-asserted-by":"crossref","first-page":"9959","DOI":"10.18632\/oncotarget.3692","article-title":"Valproic acid promotes radiosensitization in meningioma stem-like cells","volume":"6","author":"Chiou","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2023.216125_bib58","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.leukres.2011.02.021","article-title":"Hematologic improvement and response in elderly AML\/RAEB patients treated with valproic acid and low-dose Ara-C","volume":"35","author":"Corsetti","year":"2011","journal-title":"Leuk. Res."},{"key":"10.1016\/j.canlet.2023.216125_bib59","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ctrv.2007.11.003","article-title":"Valproic acid as epigenetic cancer drug: preclinical, clinical and transcriptional effects on solid tumors","volume":"34","author":"Duenas-Gonzalez","year":"2008","journal-title":"Cancer Treat Rev."},{"key":"10.1016\/j.canlet.2023.216125_bib60","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1212\/WNL.0b013e31822f02e1","article-title":"Prolonged survival with valproic acid use in the EORTC\/NCIC temozolomide trial for glioblastoma","volume":"77","author":"Weller","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.canlet.2023.216125_bib61","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1093\/neuonc\/not057","article-title":"Effect of valproic acid on seizure control and on survival in patients with glioblastoma multiforme","volume":"15","author":"Kerkhof","year":"2013","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.canlet.2023.216125_bib62","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.radonc.2015.10.009","article-title":"Antiepileptic drug use improves overall survival in breast cancer patients with brain metastases in the setting of whole brain radiotherapy","volume":"117","author":"Reddy","year":"2015","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.canlet.2023.216125_bib63","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1007\/s12094-018-1892-6","article-title":"Choice of antiepileptic drugs affects the outcome in cancer patients with seizures","volume":"20","author":"Cacho-Diaz","year":"2018","journal-title":"Clin. Transl. Oncol."},{"key":"10.1016\/j.canlet.2023.216125_bib64","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.ijrobp.2013.02.012","article-title":"Valproic acid use during radiation therapy for glioblastoma associated with improved survival","volume":"86","author":"Barker","year":"2013","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.canlet.2023.216125_bib65","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.ijrobp.2015.04.038","article-title":"A phase 2 study of concurrent radiation therapy, temozolomide, and the histone deacetylase inhibitor valproic acid for patients with glioblastoma","volume":"92","author":"Krauze","year":"2015","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.canlet.2023.216125_bib66","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s00228-016-2167-1","article-title":"Valproic acid reduces hair loss and improves survival in patients receiving temozolomide-based radiation therapy for high-grade glioma","volume":"73","author":"Watanabe","year":"2017","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.canlet.2023.216125_bib67","article-title":"Effect of valproic acid on overall survival in patients with high-grade gliomas undergoing temozolomide: a nationwide population-based cohort study in Taiwan","volume":"99","author":"Kuo","year":"2020","journal-title":"Medicine (Baltim.)"},{"key":"10.1016\/j.canlet.2023.216125_bib68","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00381-021-05278-6","article-title":"Long-term survival of an adolescent glioblastoma patient under treatment with vinblastine and valproic acid illustrates importance of methylation profiling","volume":"38","author":"Kresbach","year":"2022","journal-title":"Childs. Nerv. Syst."},{"key":"10.1016\/j.canlet.2023.216125_bib69","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1200\/JCO.2015.63.6563","article-title":"Does valproic acid or levetiracetam improve survival in glioblastoma? A pooled analysis of prospective clinical trials in newly diagnosed glioblastoma","volume":"34","author":"Happold","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2023.216125_bib70","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.28283","article-title":"A phase 2 study of valproic acid and radiation, followed by maintenance valproic acid and bevacizumab in children with newly diagnosed diffuse intrinsic pontine glioma or high-grade glioma","volume":"67","author":"Su","year":"2020","journal-title":"Pediatr. Blood Cancer"},{"key":"10.1016\/j.canlet.2023.216125_bib71","doi-asserted-by":"crossref","first-page":"105976","DOI":"10.1016\/j.phrs.2021.105976","article-title":"Relevant pharmacological interactions between alkylating agents and antiepileptic drugs: preclinical and clinical data","volume":"175","author":"Cucchiara","year":"2022","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.canlet.2023.216125_bib72","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s11060-004-2338-2","article-title":"P450 enzyme inducing and non-enzyme inducing antiepileptics in glioblastoma patients treated with standard chemotherapy","volume":"72","author":"Oberndorfer","year":"2005","journal-title":"J. Neuro Oncol."},{"key":"10.1016\/j.canlet.2023.216125_bib73","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S1474-4422(03)00435-6","article-title":"Interactions between antiepileptic and chemotherapeutic drugs","volume":"2","author":"Vecht","year":"2003","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.canlet.2023.216125_bib74","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1023\/A:1008331708395","article-title":"Nitroso-urea-cisplatin-based chemotherapy associated with valproate: increase of haematologic toxicity","volume":"12","author":"Bourg","year":"2001","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.canlet.2023.216125_bib75","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0006-2952(91)90473-I","article-title":"Magnesium reversal of lithium inhibition of beta-adrenergic and muscarinic receptor coupling to G proteins","volume":"41","author":"Avissar","year":"1991","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.canlet.2023.216125_bib76","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1038\/ncomms2320","article-title":"A safe lithium mimetic for bipolar disorder","volume":"4","author":"Singh","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2023.216125_bib77","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1006\/bbrc.2000.4169","article-title":"Lithium inhibits glycogen synthase kinase-3 by competition for magnesium","volume":"280","author":"Ryves","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.canlet.2023.216125_bib78","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.pharmthera.2014.11.016","article-title":"Glycogen synthase kinase-3 (GSK3): regulation, actions, and diseases","volume":"148","author":"Beurel","year":"2015","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.canlet.2023.216125_bib79","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1080\/15384101.2015.1030557","article-title":"Tissue inhibitor of metalloproteinase 2 inhibits activation of the \u03b2-catenin signaling in melanoma cells","volume":"14","author":"Xia","year":"2015","journal-title":"Cell Cycle"},{"key":"10.1016\/j.canlet.2023.216125_bib80","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.3389\/fonc.2019.01092","article-title":"The role of lithium in management of endocrine tumors\u2014a comprehensive review","volume":"9","author":"Thakur","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.canlet.2023.216125_bib81","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.18632\/oncotarget.2037","article-title":"GSK-3 as potential target for therapeutic irvention in cancer","volume":"5","author":"Mccubrey","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2023.216125_bib82","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1158\/1535-7163.MCT-13-0560-T","article-title":"GSK3 inhibitors regulate MYCN mRNA levels and reduce neuroblastoma cell viability through multiple mechanisms, including p53 and Wnt signaling","volume":"13","author":"Duffy","year":"2014","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.canlet.2023.216125_bib83","doi-asserted-by":"crossref","first-page":"805","DOI":"10.7150\/ijms.12429","article-title":"Lithium chloride promotes apoptosis in human leukemia NB4 cells by inhibiting glycogen synthase kinase-3 beta","volume":"12","author":"Li","year":"2015","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.canlet.2023.216125_bib84","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1038\/leu.2015.159","article-title":"Lithium chloride antileukemic activity in acute promyelocytic leukemia is GSK-3 and MEK\/ERK dependent","volume":"29","author":"Zassadowski","year":"2015","journal-title":"Leukemia"},{"key":"10.1016\/j.canlet.2023.216125_bib85","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1158\/1535-7163.MCT-06-0665","article-title":"Inactivation of glycogen synthase kinase-3\u03b2, a downstream target of the raf-1 pathway, is associated with growth suppression in medullary thyroid cancer cells","volume":"6","author":"Kunnimalaiyaan","year":"2007","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.canlet.2023.216125_bib86","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1002\/pros.20586","article-title":"Lithium suppresses cell proliferation by interrupting E2F\u2013DNA interaction and subsequently reducing S\u2013phase gene expression in prostate cancer","volume":"67","author":"Sun","year":"2007","journal-title":"Prostate"},{"key":"10.1016\/j.canlet.2023.216125_bib87","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1002\/pros.21300","article-title":"Suppression of glycogen synthase kinase 3 activity reduces tumor growth of prostate cancer in vivo","volume":"71","author":"Zhu","year":"2011","journal-title":"Prostate"},{"key":"10.1016\/j.canlet.2023.216125_bib88","doi-asserted-by":"crossref","unstructured":"Q. Zhang, Q. Zhang, H. Li, X. Zhao, H. Zhang, LiCl induces apoptosis via CHOP\/NOXA\/Mcl-1 axis in human choroidal melanoma cells, Cancer Cell Int. 21 (2021) 96, doi:10.1186\/S12935-021-01778-2.","DOI":"10.1186\/s12935-021-01778-2"},{"key":"10.1016\/j.canlet.2023.216125_bib89","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/sj.cr.7310078","article-title":"Glycogen synthase kinase-3\u03b2 positively regulates the proliferation of human ovarian cancer cells","volume":"16","author":"Cao","year":"2006","journal-title":"Cell Res."},{"key":"10.1016\/j.canlet.2023.216125_bib90","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1365-2265.2008.03349.x","article-title":"Down-regulation of NR4A1 in follicular thyroid carcinomas is restored following lithium treatment","volume":"70","author":"Camacho","year":"2009","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.canlet.2023.216125_bib91","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1590\/S0004-27302007000500003","article-title":"TSH signalling and cancer","volume":"51","author":"Garc\u00eda-Jim\u00e9nez","year":"2007","journal-title":"Arq. Bras. Endocrinol. Metabol."},{"key":"10.1016\/j.canlet.2023.216125_bib92","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0022280","article-title":"Wnt\/\u03b2-Catenin signaling pathway is a direct enhancer of thyroid transcription Factor-1 in human papillary thyroid carcinoma cells","volume":"6","author":"Gilbert-Sirieix","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.canlet.2023.216125_bib93","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.15206","article-title":"Biological basis and clinical study of glycogen synthase kinase- 3\u03b2-targeted therapy by drug repositioning for glioblastoma","volume":"8","author":"Furuta","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2023.216125_bib94","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1007\/s10517-020-05044-9","article-title":"In vitro effects of lithium carbonate on cell cycle, apoptosis, and autophagy in hepatocellular carcinoma-29 cells","volume":"170","author":"Taskaeva","year":"2020","journal-title":"Bull. Exp. Biol. Med."},{"key":"10.1016\/j.canlet.2023.216125_bib95","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/s10517-019-04621-x","article-title":"Cytological characteristics of a heterogeneous population of hepatocellular carcinoma-29 cells after injection of lithium carbonate in the experiment","volume":"167","author":"Taskaeva","year":"2019","journal-title":"Bull. Exp. Biol. Med."},{"key":"10.1016\/j.canlet.2023.216125_bib96","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/BF02787342","article-title":"Cancer morbidity in psychiatric patients: influence of lithium carbonate treatment","volume":"15","author":"Cohen","year":"1998","journal-title":"Med. Oncol."},{"key":"10.1016\/j.canlet.2023.216125_bib97","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/bdi.12361","article-title":"Lithium treatment and cancer incidence in bipolar disorder","volume":"18","author":"Martinsson","year":"2016","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.canlet.2023.216125_bib98","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1192\/bjp.bp.116.181362","article-title":"Use of lithium and cancer risk in patients with bipolar disorder: population-based cohort study","volume":"209","author":"Huang","year":"2016","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.canlet.2023.216125_bib99","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/bjc.2016.10","article-title":"Long-term use of lithium and risk of colorectal adenocarcinoma: a nationwide case\u2013control study","volume":"114","author":"Pottegard","year":"2016","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.canlet.2023.216125_bib100","doi-asserted-by":"crossref","first-page":"327","DOI":"10.3389\/fonc.2020.00327","article-title":"Phase I trial of lithium and tretinoin for treatment of relapsed and refractory non-promyelocytic acute myeloid leukemia","volume":"10","author":"Ueda","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.canlet.2023.216125_bib101","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1089\/thy.2011.0372","article-title":"Lithium as an adjuvant in the postoperative ablation of remnant tissue in low-risk thyroid carcinoma","volume":"22","author":"Yamazaki","year":"2012","journal-title":"Thyroid"},{"key":"10.1016\/j.canlet.2023.216125_bib102","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/cen.13806","article-title":"The effect of lithium on the progression-free and overall survival in patients with metastatic differentiated thyroid cancer undergoing radioactive iodine therapy","volume":"89","author":"Luo","year":"2018","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.canlet.2023.216125_bib103","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1634\/theoncologist.2010-0323","article-title":"A preclinical and clinical study of lithium in low-grade neuroendocrine tumors","volume":"16","author":"Lubner","year":"2011","journal-title":"Oncol."},{"key":"10.1016\/j.canlet.2023.216125_bib104","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1556\/650.2021.32110","article-title":"Supplementary valproate therapy for glioma patients: an alternative opportunity to enhance the efficiency of radio-chemotherapy","volume":"162","author":"Mezei","year":"2021","journal-title":"Orv. Hetil."},{"key":"10.1016\/j.canlet.2023.216125_bib105","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2515\/therapie\/2010029","article-title":"Pour le groupe Suivi Th\u00e9rapeutique Pharmacologique de la Soci\u00e9t\u00e9 Fran\u00e7aise de Pharmacologie et de Th\u00e9rapeutique, Therapeutic drug monitoring of valproate","volume":"65","author":"Bentu\u00e9-Ferrer","year":"2010","journal-title":"Therapie"},{"key":"10.1016\/j.canlet.2023.216125_bib106","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.canlet.2018.06.002","article-title":"Does metronomic chemotherapy induce tumor angiogenic dormancy? A review of available preclinical and clinical data","volume":"432","author":"Natale","year":"2018","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2023.216125_bib107","doi-asserted-by":"crossref","first-page":"42396","DOI":"10.18632\/oncotarget.6377","article-title":"Potent efficacy of metronomic topotecan and pazopanib combination therapy in preclinical models of primary or late stage metastatic triple-negative breast cancer","volume":"6","author":"Di Desidero","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2023.216125_bib108","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/S0140-6736(21)00246-4","article-title":"The SANAD II study of the effectiveness and cost-effectiveness of valproate versus levetiracetam for newly diagnosed generalised and unclassifiable epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial","volume":"397","author":"Marson","year":"2021","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.canlet.2023.216125_bib109","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106290","article-title":"Association of plasma levetiracetam concentration, MGMT methylation and sex with survival of chemoradiotherapy-treated glioblastoma patients","volume":"181","author":"Cucchiara","year":"2022","journal-title":"Pharmacol. Res."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383523000769?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383523000769?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T16:07:29Z","timestamp":1759594049000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383523000769"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":109,"alternative-id":["S0304383523000769"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2023.216125","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Valproate and lithium: Old drugs for new pharmacological approaches in brain tumors?","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2023.216125","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"216125"}}